2.4.0.80023 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)truefalsefalse1false USDfalsefalse$From2013-01-01to2013-06-30http://www.sec.gov/CIK0001402785duration2013-01-01T00:00:002013-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2012-01-01to2012-06-30http://www.sec.gov/CIK0001402785duration2012-01-01T00:00:002012-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$From2003-09-13to2013-06-30http://www.sec.gov/CIK0001402785duration2003-09-13T00:00:002013-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 2fpmi_CommitmentsAndContingenciesAdditionalDetailsAbstractfpmi_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Commitments and contingencies additional details2false 3us-gaap_RevenueRecognitionMilestoneMethodMilestoneus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00The renegotiated license extends the timelines for the development milestones by two years in exchange for a $20,000 paymentfalsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringA description of each milestone and related contingent consideration as well as a description of whether or not each milestone(s) is considered substantive.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 28 -Section 50 -Paragraph 2 -Subparagraph (b,c) -URI http://asc.fasb.org/extlink&oid=19771982&loc=SL6892177-166501 false0Renegotiated license stipulates3false 3fpmi_PaymentOfAggregateCompensationforClinicalResearchServicesfpmi_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse346234346234USD$falsetruefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryCustom Element.No definition available.false2Payment of an aggregate compensation to SGS4false 3fpmi_AmountPaidUponExecutionOfLetterOfIntentfpmi_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse290271290271falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryCustom Element.No definition available.false2Amount paid upon execution of the LOI5false 3fpmi_BonusForKeyCompanyExecutiveIfCompanyExecuteTransactionsAsSpecifiedInContractfpmi_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse10000001000000falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryCustom Element.No definition available.false2Bonus for key company executive if the Company execute transactions as specified in the contract6false 3fpmi_ExecutiveEmploymentContractConditionsfpmi_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00should the Company execute transactions as specified in the contract, including the sale of substantially all of the Company’s assets or stock or a merger transaction, any of which resulting in compensation to the Company’s stockholders aggregating in excess of $50 million for such transactionfalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringCustom Element.No definition available.false0Executive employment contract conditions7false 3fpmi_LeaseTermForOfficeSpacefpmi_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse003 yearsfalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaCustom Element.No definition available.false0Lease term for office space8false 3fpmi_AnnualMinimumLeasePaymentsfpmi_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4560045600falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse4560045600falsefalsefalsexbrli:monetaryItemTypemonetaryCustom Element.No definition available.false2Annual minimum lease payments9false 3fpmi_SecurityDepositForLeasefpmi_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse57005700falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse57005700falsefalsefalsexbrli:monetaryItemTypemonetaryCustom Element.No definition available.false2Security deposit for lease10false 3us-gaap_LeaseholdImprovementsGrossus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2517125171falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse2517125171falsefalsefalsexbrli:monetaryItemTypemonetaryGross amount, at the balance sheet date, of long-lived, depreciable assets that are an addition or improvement to assets held under lease arrangement.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 5 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 4 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6812-107765 false2Leasehold improvements11false 3us-gaap_LicenseCostsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2truefalsefalse3000030000falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryCosts incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2(e)) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 false2Annual license maintenance fee12false 3us-gaap_PaymentsForRentus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1570015700USD$falsetruefalse2truefalsefalse3510035100USD$falsetruefalse3truefalsefalse303136303136USD$falsetruefalsexbrli:monetaryItemTypemonetaryCash payments to lessor's for use of assets under operating leases.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (g) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 27 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false2Rent expensesfalseCOMMITMENTS AND CONTINGENCIES (Details Narrative) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://flouropharmamedical.com/role/CommitmentsAndContingenciesDetailsNarrative312